Print Page  Close Window

2017 News Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
Ra Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

Read More

Ra Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update

Read More

Ra Pharmaceuticals Receives Orphan Drug Designation from the U.S. FDA for RA101495 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Read More

Ra Pharmaceuticals Announces Publication of Positive Preclinical Data with RA101295 for the Treatment of Escherichia Coli Sepsis

Read More

Ra Pharmaceuticals Announces Initial Data from Phase 2 Clinical Trial of RA101495 in PNH

Read More

Ra Pharmaceuticals Presents Data on Oral Small Molecule Complement Inhibitors at the 22nd Congress of the European Hematology Association

Read More

Ra Pharmaceuticals to Host Conference Call on Initial Phase 2 Data for RA101495 in PNH

Read More

Ra Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference

Read More

Ra Pharmaceuticals to Present at the 22nd Congress of the European Hematology Association

Read More

Ra Pharmaceuticals to Present at the UBS 2017 Global Healthcare Conference

Read More

Ra Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update

Read More

Ra Pharmaceuticals Initiates Dosing of RA101495 in PNH Patients

Read More

Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

Read More

Ra Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference

Read More

Ra Pharma Supports 10th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases

Read More